Investing.com - Nurix reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Nurix announced earnings per share of $-0.90 on revenue of $10.79M. Analysts polled by Investing.com anticipated EPS of $-0.95 on revenue of $12.07M.
Nurix shares are down 59% from the beginning of the year and are trading at $11.82 , down-from-52-week-high.
Nurix follows other major Healthcare sector earnings this month
Nurix's report follows an earnings beat by Merck ADR on Friday, September 9, 2022, who reported EPS of $0.5392 on revenue of $5.69B, compared to forecasts EPS of $0.5165 on revenue of $5.57B.
Carl Zeiss Meditec ADR had beat expectations on Friday, September 9, 2022 with third quarter EPS of $0.7134 on revenue of $486.54M, compared to forecast for EPS of $0.7116 on revenue of $486.31M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar